Numinus Wellness Inc. (TSXV:NUMI) agreed to acquire the Neurology Centre of Toronto for CAD 1 million on July 2, 2021. Numinus will pay CAD 0.3 million in cash and CAD 0.2 million in Numinus shares upon closing and future performance-based payments totaling up to CAD 0.5 million in Numinus shares to complete the transaction. Neurology Centre of Toronto reported gross revenue of CAD 1 million for December 31, 2020. Evan Lewis, recognized for advancing the use of medical cannabis to treat complex neurologic disorders, will join Numinus as Vice President, Psychedelic Neurology Services upon completion of the acquisition. All of NCT's staff - including medical doctors, nurses, physician assistants, occupational therapists, psychotherapists, physiotherapists, nutritionists and administrative staff - are expected to remain with Numinus post transaction closing. The transaction is subject to a number of conditions, including the approval of the TSX Venture Exchange. As of the date hereof, Numinus and NCT management have completed their due diligence. The Numinus Wellness Inc. anticipates that the acquisition of NCT will be completed by the end of August 2021.